East by South West 5th Annual Update in Nephrology
Target Audience
Nurse Practitioner, Physician, and Physician Assistant.
Learning Objectives
1. Outline new diagnostic and treatment recommendations for resistant HTN and its management
2. Discuss advances in the role of AKI in CKD
3. Discuss updated in Treatment of ANCA vasculitis
4. Discuss how to appropriately manage and updates in management of secondary hyperparathyroidism and Bone mineral disorders in ESKD and transplant.
5. Explain the pathophysiology of and updated optimal treatment options for management of AKI in liver and heart disease
6. Updates on Out-patient dialysis machines
7. Outline new diagnostic and treatment recommendations for Alports syndrome
Course Directors:
Pooja Amarapurkar, MD
Christos Argyropoulos, MD, PhD
Faculty Listing
- Blaise Abramovitz, DO, FASN – University of Pittsburgh; Renal-Electrolyte Division, Assistant Professor of Medicine; Mercy Hospital, UPMC, Director of Community Practice, Division of Nephrology, Pittsburgh PA
- Syeda Ahmad, MD – University of Pittsburgh; Renal-Electrolyte Division, Assistant Professor of Medicine, Director of Glomerular Disease Center, Pittsburgh, PA
- Pooja Amarapurkar, MD – University of Pittsburgh; Renal-Electrolyte Division, Assistant Professor of Medicine, Director of Onco-Nephrology, Pittsburgh, PA
- Christos Argyropoulos, MD, PhD – University of New Mexico; Internal Medicine, Chief, Division of Nephrology, Associate Professor of Medicine, Albuquerque, NM
- Pablo Garcia, MD – University of New Mexico; Internal Medicine, Chair, Professor of Medicine, Albuquerque, NM
- Manisha Jhamb, MD, MPH – University of Pittsburgh; Renal-Electrolyte Division, Associate Chief, Director of Center for Population Health Management, Pittsburgh, PA
- Paul Palevsky, MD – University of Pittsburgh; Renal-Electrolyte Division, Critical Care Medicine, and Clinical & Translation Science, Professor of Medicine; Chief, Kidney Medicine Section, VA Pittsburgh Healthcare System, Pittsburgh, PA
- Chethan Puttarajappa, MD, MS – University of Pittsburgh; Renal-Electrolyte Division, Associate Professor of Medicine, Pittsburgh, PA
- Janani Rangaswami, MD, FACP, FCRS, FAHA – George Washington University; School of Medicine and Health Sciences, Professor of Medicine; Director of Cardiorenal Program, Washington, DC
- Helbert Rondon, MD, MS – University of Pittsburgh; Renal-Electrolyte Division, Professor of Medicine; Chief, Renal Services, UPMC Magee-Women’s Hospital, Pittsburgh, PA
- Mark Unruh, MD, MS – University of New Mexico; Professor of Medicine, Chair, Department of Internal Medicine, Albuquerque, NM
- Juan Carlos Velez, MD – University of Queensland; Oschner Clinical School, Associate Professor, New Orleans, LA
Staff Listing
- Maria Delesio, ABM, AGS – University of Pittsburgh; Department of Medicine, Renal-Electrolyte Division, Pittsburgh Center for Kidney Research - O’Brien Center, Business Administration Manager, Pittsburgh, PA
Faculty & Staff Disclosure
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relations were disclosed:
- Dr. Paul Palevsky has grant/research support from Baxter Inc. and is a consultant for Chiesi USA (an affiliate of Chiesi Farmaceutici S.p.A) and AkiCept LLC.
- Dr. Chethan Puttarajappa is a consultant for Replimune Group, Inc.
- Dr. Janani Rangaswami is a consultant for Boehringer Ingelheim, Pryocyrion, and Bayer as well as a CE Speakers’ Bureau member for Boehringer Ingelheim.
- Dr. Christos Argyropoulos has grant/research support from Quanta Dialysis Technologies Ltd.
- Dr. Manisha Jhamb has grant/research support from CKD Leaders Network and is a consultant for Boehringer Ingelheim, Eli-Lilly and Company, and CKD Leaders Network.
- Dr. Juan Carlos Velez is a consultant for Mallinckrodt Pharmaceuticals, Calliditas Therapeutics, and Travere Therapeutics and is a CE Speakers’ Bureau member of Mallinckrodt Pharmaceuticals.
- Dr. Syeda Ahmad is a consultant and a part of the CE Speakers’ Bureau for Travere Therapeutics and was previously a consultant for Novartis.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC/University of Pittsburgh Medical Center or Affiliate and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgement when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This educational activity is approved for 10.5 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 10.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 10.50 Attendance
Price
Registration Information:
Registration Categories
Registration before 8/17 | Registration 8/18 - 9/6 | Onsite Registration 9/10-9/14 | |
MD, DO | 400 | 440 | 465 |
RN, NP, PA, Other | 350 | 390 | 415 |
Fellow/Resident/Medical Student | 100 | 140 | 165 |
UPMC Renal Faculty, Fellow, RN, NP or PA | 0 | 0 | 0 |
All cancellations must be sent via email, amarapurkarpd@upmc.edu and rondonberriosh@upmc.edu. Cancellations received on or before august 22nd 2024 will be refunded with a 50$ processing fee deduction. No refunds will be made after 08/22/24
Contact information for questions: amarapurkarpd@upmc.edu and rondonberriosh@upmc.edu
For more information, please contact Pooja Amarapurkar at: amarapurkarpd@upmc.edu